| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Apolipoprotein AIApolipoprotein BHDLABCA1Paraoxonase1Serum Amyloid AInflammation (BASKET)Akute phase reactionLipoprotein associated phospholipase A2sPLA2| 1 | 2007 | Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. | 
| + | - | nl | Vasc Health Risk Manag 3(4):491-502 (2007) Olofsson SO |
| 2 | 2002 | How the lipid-free structure of the N-terminal truncated human apoA-I converts to the lipid-bound form: new insights from NMR and X-ray structural comparison. | 
| + | - | nl | FEBS Lett 529(2-3):157-61 (2002) |
| 3 | 1999 | A novel amyloidogenic variant of apolipoprotein AI: implications for a conformational change leading to cardiomyopathy. |
| + | - | nl | Am J Pathol 154(1):11-4 (1999) |
| 4 | 2008 | Three-dimensional models of HDL apoA-I: implications for its assembly and function. |
| + | - | nl | J Lipid Res 49(9):1875-83 (2008) Thomas MJ |
| 5 | 2000 | Apolipoprotein A-I: structure-function relationships. |
| + | - | nl | J Lipid Res 41(6):853-72 (2000) |
| 6 | 1999 | Hormonal regulation of apolipoprotein AI. |
| + | - | nl | J Mol Endocrinol 22(2):103-11 (1999) |
| 7 | 2011 | Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. |
| + | - | nl | Circ J 75(7):1533-8 (2011) |
| 8 | 2004 | Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease. |
| + | - | nl | Arterioscler Thromb Vasc Biol 24(10):1755-60 (2004) |
| 9 | 2005 | Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? |
| + | - | nl | J Lipid Res 46(3):389-403 (2005) |
